SRRA logo

Sierra Oncology (SRRA) Cash From Investing

Annual CFI

-$72.00 K
-$60.00 K-500.00%

December 31, 2021

Summary

Performance

1-Year Change

-500%

3-Year Change

+38.98%

5-Year Change

+21.74%

15-Year Change

+21.74%

SRRA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.45 M
SRRA annual cash flow from investing activities is currently -100.76% below its historical high of $9.45 million

3-Year Low

-$72.00 K
SRRA annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
SRRA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
SRRA next annual earnings announcement has not yet been scheduled

OtherSRRAcash flowmetrics:

Annual CFF

$79.81 M
SRRA annual cash flow from financing activities is $79.81 million

Annual CFO

-$78.96 M
SRRA annual cash flow from operations is -$78.96 million

Annual FCF

-$79.04 M
SRRA annual free cash flow is -$79.04 million

Annual CAPEX

-
SRRA annual capital expenditures value is unknown

Quarterly CFI

-$62.00 K
-$30.00 K-93.75%

March 31, 2022

Summary

Performance

3-Month Change

-93.75%

1-Year Change

-100%

3-Year Change

-342.86%

5-Year Change

+20.51%

SRRA Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.90 M
SRRA quarterly cash flow from investing activities is currently -100.63% below its historical high of $9.90 million

3-Year Low

-$62.00 K
SRRA quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
SRRA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
SRRA next earnings announcement has not yet been scheduled

OtherSRRAcash flowmetrics:

Quarterly CFF

$195.06 M
SRRA quarterly cash flow from financing activities is $195.06 million

Quarterly CFO

-$25.74 M
SRRA quarterly cash flow from operations is -$25.74 million

Quarterly FCF

-$25.80 M
SRRA quarterly free cash flow is -$25.80 million

Quarterly CAPEX

-
SRRA quarterly capital expenditures value is unknown

TTM CFI

-$134.00 K
-$62.00 K-86.11%

March 31, 2022

Summary

Performance

3-Month Change

-86.11%

1-Year Change

-1016.67%

3-Year Change

-243.59%

5-Year Change

-243.59%

SRRA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.71 M
SRRA TTM cash flow from investing activities is currently -101.38% below its historical high of $9.71 million

3-Year Low

-$134.00 K
SRRA TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
SRRA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
SRRA next earnings announcement has not yet been scheduled

OtherSRRAcash flowmetrics:

TTM CFF

$254.29 M
SRRA TTM cash flow from financing activities is $254.29 million

TTM CFO

-$87.74 M
SRRA TTM cash flow from operations is -$87.74 million

TTM FCF

-$87.87 M
SRRA TTM free cash flow is -$87.87 million

TTM CAPEX

-
SRRA TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SRRA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-500.0%-100.0%-1016.7%
3 y3 years+39.0%-342.9%-243.6%
5 y5 years+21.7%+20.5%-243.6%

SRRA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+93.8%at low+86.1%at low
5 y5-year+500.0%at low<-9999.0%at low+1016.7%at low
alltimeall time-100.8%>+9999.0%-100.6%>+9999.0%-101.4%+7879.1%

Sierra Oncology Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2022
-
-$62.00 K(+93.8%)
-$134.00 K(+86.1%)
Dec 2021
-$72.00 K(+500.0%)
-$32.00 K(<-9900.0%)
-$72.00 K(+80.0%)
Sep 2021
-
$0.00(-100.0%)
-$40.00 K(0.0%)
Jun 2021
-
-$40.00 K(<-9900.0%)
-$40.00 K(+233.3%)
Mar 2021
-
$0.00(0.0%)
-$12.00 K(0.0%)
Dec 2020
-$12.00 K(-69.2%)
$0.00(0.0%)
-$12.00 K(-33.3%)
Sep 2020
-
$0.00(-100.0%)
-$18.00 K(-43.8%)
Jun 2020
-
-$12.00 K(<-9900.0%)
-$32.00 K(+28.0%)
Mar 2020
-
$0.00(-100.0%)
-$25.00 K(-35.9%)
Dec 2019
-$39.00 K(-66.9%)
-$6000.00(-57.1%)
-$39.00 K(-57.6%)
Sep 2019
-
-$14.00 K(+180.0%)
-$92.00 K(-14.0%)
Jun 2019
-
-$5000.00(-64.3%)
-$107.00 K(-18.9%)
Mar 2019
-
-$14.00 K(-76.3%)
-$132.00 K(+11.9%)
Dec 2018
-$118.00 K(+28.3%)
-$59.00 K(+103.4%)
-$118.00 K(+100.0%)
Sep 2018
-
-$29.00 K(-3.3%)
-$59.00 K(+68.6%)
Jun 2018
-
-$30.00 K(<-9900.0%)
-$35.00 K(+150.0%)
Mar 2018
-
$0.00(0.0%)
-$14.00 K(-84.8%)
DateAnnualQuarterlyTTM
Dec 2017
-$92.00 K(-46.2%)
$0.00(-100.0%)
-$92.00 K(-31.9%)
Sep 2017
-
-$5000.00(-44.4%)
-$135.00 K(+31.1%)
Jun 2017
-
-$9000.00(-88.5%)
-$103.00 K(+8.4%)
Mar 2017
-
-$78.00 K(+81.4%)
-$95.00 K(-44.4%)
Dec 2016
-$171.00 K(-101.8%)
-$43.00 K(-259.3%)
-$171.00 K(+6.2%)
Sep 2016
-
$27.00 K(-2800.0%)
-$161.00 K(-101.7%)
Jun 2016
-
-$1000.00(-99.4%)
$9.71 M(+3.7%)
Mar 2016
-
-$154.00 K(+366.7%)
$9.36 M(-0.9%)
Dec 2015
$9.45 M(-191.9%)
-$33.00 K(-100.3%)
$9.45 M(+1.4%)
Sep 2015
-
$9.90 M(-2920.8%)
$9.31 M(-187.1%)
Jun 2015
-
-$351.00 K(+394.4%)
-$10.69 M(+3.3%)
Mar 2015
-
-$71.00 K(-57.0%)
-$10.35 M(+0.7%)
Dec 2014
-$10.28 M(>+9900.0%)
-$165.00 K(-98.4%)
-$10.28 M(+1.6%)
Sep 2014
-
-$10.11 M(>+9900.0%)
-$10.12 M(>+9900.0%)
Jun 2014
-
-$12.00 K(<-9900.0%)
-$12.00 K(<-9900.0%)
Mar 2014
-
$0.00
$0.00
Dec 2013
-$2000.00
-
-

FAQ

  • What is Sierra Oncology annual cash flow from investing activities?
  • What is the all time high annual CFI for Sierra Oncology?
  • What is Sierra Oncology annual CFI year-on-year change?
  • What is Sierra Oncology quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Sierra Oncology?
  • What is Sierra Oncology quarterly CFI year-on-year change?
  • What is Sierra Oncology TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Sierra Oncology?
  • What is Sierra Oncology TTM CFI year-on-year change?

What is Sierra Oncology annual cash flow from investing activities?

The current annual CFI of SRRA is -$72.00 K

What is the all time high annual CFI for Sierra Oncology?

Sierra Oncology all-time high annual cash flow from investing activities is $9.45 M

What is Sierra Oncology annual CFI year-on-year change?

Over the past year, SRRA annual cash flow from investing activities has changed by -$60.00 K (-500.00%)

What is Sierra Oncology quarterly cash flow from investing activities?

The current quarterly CFI of SRRA is -$62.00 K

What is the all time high quarterly CFI for Sierra Oncology?

Sierra Oncology all-time high quarterly cash flow from investing activities is $9.90 M

What is Sierra Oncology quarterly CFI year-on-year change?

Over the past year, SRRA quarterly cash flow from investing activities has changed by -$62.00 K (-100.00%)

What is Sierra Oncology TTM cash flow from investing activities?

The current TTM CFI of SRRA is -$134.00 K

What is the all time high TTM CFI for Sierra Oncology?

Sierra Oncology all-time high TTM cash flow from investing activities is $9.71 M

What is Sierra Oncology TTM CFI year-on-year change?

Over the past year, SRRA TTM cash flow from investing activities has changed by -$122.00 K (-1016.67%)